Company Filing History:
Years Active: 2021
Title: Gabriela Andrejeva: Innovator in Cancer Therapeutics
Introduction
Gabriela Andrejeva is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of cancer therapeutics through her innovative research and development of monoclonal antibodies.
Latest Patents
Gabriela holds a patent for "Therapeutic SIRP-α antibodies." This patent includes anti-SIRPα monoclonal antibodies (anti-SIRPα mAbs), which feature distinct functional profiles. The patent also encompasses related compositions and methods for using anti-SIRPα mAbs as therapeutics for the prevention and treatment of both solid and hematological cancers. Additionally, it provides amino acid sequences of exemplary anti-SIRPα monoclonal antibodies. She has 1 patent to her name.
Career Highlights
Gabriela is currently associated with Arch Oncology, Inc., where she continues to advance her research in cancer treatment. Her work is pivotal in developing new therapeutic options for patients suffering from various forms of cancer.
Collaborations
Gabriela collaborates with notable colleagues, including Robyn Puro and Ronald R Hiebsch, to further enhance the impact of her research in the field.
Conclusion
Gabriela Andrejeva's innovative work in the development of therapeutic antibodies positions her as a key figure in the fight against cancer. Her contributions are vital for advancing cancer treatment options and improving patient outcomes.